Primary Graft Dysfunction

• 

  Subject Areas on Research

  • A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. 
  • ACR Appropriateness Criteria® Renal Transplant Dysfunction. 
  • Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study. 
  • Advances in Human Lung Transplantation. 
  • Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. 
  • Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia. 
  • Association between primary graft dysfunction and acute kidney injury after orthotopic heart transplantation - a retrospective, observational cohort study. 
  • Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury. 
  • Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States - a cohort study. 
  • Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. 
  • Clinical risk factors for primary graft dysfunction after lung transplantation. 
  • Commentary: Failing grades. 
  • Construct validity of the definition of primary graft dysfunction after lung transplantation. 
  • Contemporary trends in PGD incidence, outcomes, and therapies. 
  • Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. 
  • Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. 
  • Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. 
  • Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction. 
  • Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. 
  • Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. 
  • Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. 
  • Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. 
  • Expanding donor availability in lung transplantation: A case report of 5000 miles traveled. 
  • Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study. 
  • Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. 
  • Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction. 
  • Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus. 
  • Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study. 
  • Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. 
  • Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. 
  • Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. 
  • Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis. 
  • Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. 
  • Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. 
  • Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. 
  • Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. 
  • Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. 
  • Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. 
  • Perioperative Management of Bleeding and Transfusion for Lung Transplantation. 
  • Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. 
  • Plasma kallikrein predicts primary graft dysfunction after heart transplant. 
  • Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. 
  • Pre-transplant weight loss and clinical outcomes after lung transplantation. 
  • Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. 
  • Primary Graft Dysfunction after Heart Transplantation - Unravelling the Enigma. 
  • Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors. 
  • Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing. 
  • Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. 
  • Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. 
  • Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation. 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Re: Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. 
  • Reflux and allograft dysfunction: is there a connection? 
  • Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. 
  • Report from a consensus conference on primary graft dysfunction after cardiac transplantation. 
  • Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. 
  • Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease. 
  • Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. 
  • The Association of Increased FFP:RBC Transfusion Ratio to Primary Graft Dysfunction in Bleeding Lung Transplantation Patients. 
  • The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. 
  • The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. 
  • Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. 
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.